Healthy Aging after Acute Pancreatitis Conference

HPSG 2026 PRELIMINARY

Healthy Aging after Acute PancreatitisChallenges and Opportunities

An international conference on long-term outcomes after acute pancreatitis in cooperation with the Hungarian Pancreatic Study Group.

20–22 November 2026 Budapest · Semmelweis University · CTM

Provisional venue

Budapest · 22 Baross Street

Semmelweis University
Centre for Translational Medicine

BC22 Office Building, ground floor
Marcus Aurelius Seminar Room
1085 Budapest, Baross u. 22.

Preliminary themes

Clinical and translational research

  • Long-term outcomes after pancreatitis.
  • Experimental pancreatitis and genetics.
  • Endoscopy and acute in-hospital care.
  • Pancreatic cancer; multidisciplinary care and risk factors.

Organisation

Organisers

Hungarian Pancreatic Study Group (HPSG)

Semmelweis University
Centre for Translational Medicine (CTM)

Preliminary scientific programme

Expand each day to view the detailed schedule. Presentation titles follow the draft programme; the Hungarian opening title is shown in English translation. All timings and speaker participation are preliminary.

Preliminary programme

Friday · 20 November

Opening lecture · Experimental pancreatitis and genetics

Provisional time window: 13:30–17:55

Detailed preliminary programme

20 November 2026 · Preliminary programme, subject to change.

13:30–14:00 · Preliminary session

Open Lecture

  1. –

    30 min

    Prof. Hegyi Péter

    Long-term consequences after pancreatitis

14:00–16:00 · Preliminary session

Experimental Pancreatitis and Genetics

  1. –

    30 min

    Miklós Sahin-Tóth

    What is trypsin-dependent pancreatitis?

  2. –

    10 min

    Bernadett Nagy/Eszter Hegyi

    The PRSS3P2–TRY7 deletion copy number variant in chronic pancreatitis: the potential role of alcohol exposure

    Speaker to be confirmed

  3. –

    30 min

    Németh Balázs

    Novel genetic risk factors in chronic pancreatitis

  4. –

    30 min

    Andrea Geisz-Fremy

    Targeting Trypsin to Treat Pancreatitis

  5. –

    10 min

    Berke Gergő

    Therapeutic trypsin inhibition in pancreatitis with AAV8-SPINK1 minigene

  6. –

    10 min

    Erik Orján

    The role and inhibition of ferroptosis in models of acute pancreatitis: in vivo and in vitro studies

16:00–16:15Coffee break

16:15–17:55 · Preliminary session

Experimental Pancreatitis and Genetics

  1. –

    30 min

    Jason Bruce

    Insulin protection during acute pancreatitis

  2. –

    10 min

    Ola Salamah

    TRPA1 differentially regulates pancreatic injury and fibrotic remodeling in acute and chronic pancreatitis

  3. –

    30 min

    Andraž Stožer

    Functional defects in stimulus-secretion coupling in the HFD-tacrolimus rat model of type 2 diabetes mellitus

  4. –

    30 min

    József Maléth

    Translational studies in pancreatic diseases – form the bench to the bedside?

Saturday · 21 November

Endoscopy I · Acute pancreatitis · Pancreatic cancer

Provisional time window: 08:05–18:30

Detailed preliminary programme

21 November 2026 · Preliminary programme, subject to change.

08:05–09:40 · Preliminary session

Pancreas diseases - Endoscopy (Session 1 – Saturday morning)

  1. –

    5 min

    Erőss Bálint

    Opening presentation/speech

  2. –

    30 min

    Rogier P. Voermans

    Endoscopic Management of Infected Necrotizing Pancreatitis: Insights from the Upcoming ESGE Guideline

  3. –

    10 min

    Gábor Gieszinger

    Microbiological characteristics of walled-off pancreatic necrosis based on samples obtained during endoscopic ultrasound-guided drainage

  4. –

    30 min

    John Gásdal Karstensen

    WON and Done? EUS-Guided Endoscopic Therapy from Drainage to Accelerated Necrosectomy

  5. –

    10 min

    Tom Brand

    Pancreatic Necrosis: What We Know, What We Do and What We Need to Test

  6. –

    10 min

    Klaudia Káplár

    Walled-off pancreatic necrosis (WOPN)

    Working title · final presentation title to be confirmed

09:40–10:00Coffee break

10:00–12:40 · Preliminary session

Acute Pancreatitis - Diagnosis and In-Hospital Care

  1. –

    30 min

    Dhiraj Yadav

    Sphincterotomy for Acute Recurrent Pancreatitis (SHARP) Trial

  2. –

    10 min

    Edina Tari

    Prophylactic endoscopic sphincterotomy in patients unfit for cholecystectomy after an acute biliary pancreatitis episode (PROSECCO): study protocol for an open-label, two-armed, randomised controlled trial

  3. –

    10 min

    Eperjesi Orsolya

    Pancreatic Calcification in Acute-on-Chronic Pancreatitis: Association with Disease Severity and Clinical Management

  4. –

    10 min

    Ruben Borbély

    Automated CT radiomics and clinical variables for predicting new-onset diabetes or prediabetes one year after acute pancreatitis: multicentre development and external validation

  5. –

    30 min

    Soumya Jagannath Mahapatra

    Organ failure in Acute pancreatitis: upcoming therapies

  6. –

    10 min

    Barna Boglárka

    Acute Pancreatitis Exploration (APEX) database - High-Resolution Longitudinal Registry for Acute Pancreatitis

  7. –

    10 min

    Tamás Szili-Torok

    OPTIMAP: Optimized Prediction Tool for Mortality in Acute Pancreatitis

  8. –

    10 min

    Soós Gergely

    Investigating the predictive value of nutritional status on mortality and severity in Acute Pancreatitis: A Systematic Review and Meta-Analysis

  9. –

    10 min

    Katalin Márta

    Early feeding in acute pancreatitis

  10. –

    10 min

    Edina Tari

    Early changes in renal function predict key clinical outcomes in acute pancreatitis: a multicentre registry-based study

  11. –

    10 min

    Koral Aviv

    Neutrophil-to-Lymphocyte Ratio for Predicting Infected Pancreatic Necrosis: A Systematic Review and Meta-Analysis

  12. –

    10 min

    Zoltán Bánfalvi

    DOAC versus Low Molecular Weight Heparin for Acute Pancreatitis-Associated Splanchnic Vein Thrombosis: A protocol for a Randomized Controlled Trial

12:40–13:40Lunch break / free time

13:40–15:50 · Preliminary session

Pancreatic Cancer

  1. –

    30 min

    Hana Algül

    Current Developments in Pancreatic Cancer. How will we treat PDAC patients in 10 years?

  2. –

    10 min

    Klaudia Káplár

    Investigating the Effect of Waiting Time to Surgery on Survival in Patients with Resectable PDAC

  3. –

    30 min

    Jason Bruce

    Plasma membrane Ca2+-ATPase (PMCA4) as a potential drug target for pancreatic cancer

  4. –

    10 min

    Enikő Tóth

    Resect or Preserve? Arterial Resection and Divestment in the Surgical Management of Pancreatic Cancer: A Systematic Review and Meta-analysis

  5. –

    30 min

    Christopher Lee Wolfgang

    Current Concepts in the Surgical Management of Pancreatic Cancer

  6. –

    10 min

    Sándor Orbán

    Primary Tumor Resection and Survival in Metastatic Grade 1–2 Well-Differentiated Pancreatic Neuroendocrine Tumors: A SEER Registry Analysis

  7. –

    10 min

    Balla Vivien

    RECAP study: Renal Cell Carcinoma Metastasis of the Pancreas, International multicenter data collection

15:50–16:10Coffee break

16:10–18:30 · Preliminary session

Pancreatic Cancer

  1. –

    30 min

    Tamás Gonda

    Early detection to interception of pancreatic cancer

  2. –

    10 min

    Roxana Grigorovici

    Small Pancreatic Tumors: Is EUS the best detection tool? – A Systematic Review and Meta-Analysis

  3. –

    10 min

    Matteo Tacelli

    Machine-Learning-Powered Endoscopic Ultrasound Detects Morphological Features for Predicting Malignancy in IPMNs: Results from the “IMAGE” Study from a Tertiary Referral Center

  4. –

    10 min

    Daniel Marino

    Cyst-Derived and Concomitant Pancreatic Cancer During IPMN Surveillance: A Systematic Review and Meta-Analysis

  5. –

    10 min

    Zsófia Román

    Hemoglobin A1c Levels and the Risk of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis

  6. –

    30 min

    Vinciane Rebours

    Presentation title to be confirmed.

  7. –

    10 min

    Lőrinc Ulmann

    Prognostic value of microRNA expression in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis

  8. –

    30 min

    Sanjay Pandanaboyana

    Caregiver burden, unmet needs, and quality of life at diagnosis among informal caregivers of patients with pancreatic cancer: PAN-CARER study

Sunday · 22 November

Endoscopy II · Multidisciplinary care and risk factors

Provisional time window: 08:30–13:05

Detailed preliminary programme

22 November 2026 · Preliminary programme, subject to change.

08:30–10:15 · Preliminary session

Pancreas diseases - Endoscopy (Session 2 – Sunday morning)

  1. –

    5 min

    Erőss Bálint

    Opening presentation/speech

  2. –

    30 min

    Cecilia Binda

    Endoscopic Biliary Drainage in Pancreatic Ductal Adenocarcinoma

  3. –

    10 min

    Kollányi Gergely

    Diagnostic Accuracy of ERCP-guided biliary and pancreatic duct tissue sampling in Pancreatic Ductal Adenocarcinoma

  4. –

    10 min

    Edina Tari

    Impact of papilla morphology on advanced cannulation techniques in ERCP: insights from an international survey

  5. –

    30 min

    Nitin Jagtap

    Endoscopic Interventions for Disconnected Pancreatic Duct Syndrome

  6. –

    10 min

    Dorottya Tarján

    Effectiveness and safety of ERCP and Cholecystectomy in Pregnant Women with Biliary Pancreatitis

  7. –

    10 min

    Yoon Kee Beck

    Microbiological Profiles of Bile Culture in Patients with Cholangitis Undergoing ERCP

10:15–10:35Coffee break

10:35–12:05 · Preliminary session

Pancreas Diseases - Multidisciplinary Care and Risk Factors

  1. –

    10 min

    Boros Hédi

    Clinical Outcomes Associated with Depression and Anxiety in Pancreatic Cancer: A Systematic Review and Meta-analysis

  2. –

    10 min

    Rita Nagy

    Clinical characteristics and outcomes in patients with pancreatitis and comorbid depression and anxiety: a prospective cohort study

  3. –

    30 min

    Viktória Venglovecz

    The Pancreatitis Continuum: Identifying Early Chronic Pancreatitis Before Established Disease

  4. –

    10 min

    Dalma Köves-Dobszai

    Lifestyle and Acute Pancreatitis: New Insights from the International LIFESPAN Case–Control Study

  5. –

    10 min

    Mónika Lipp

    Cholesterol as a determinant of pancreatic diseases. Post-hoc analysis of the GOULASH trial

  6. –

    10 min

    Olga Zahariev

    The predictive value of nutritional status on mortality and severity in Acute Pancreatitis: A prospective cohort study

  7. –

    10 min

    Veronika Lillik

    The Heart of Acute Pancreatitis: Cardiac Abnormalities and Outcomes in a Multicentre Registry-Based Cohort

12:05–13:05Lunch break / free time

Daily time windows include the breaks shown. Speaker names and presentation titles indicate planned programme items, not final confirmation.

Details and participation

Preliminary organisational information.

Registration and fees — to be confirmed

This preliminary information does not include a final registration deadline or fee schedule.

For registration opening dates, application deadlines, any early bird options and participation fees, please contact the organisers: hpsg2026@gmail.com.

Scientific committee — preliminary list

The composition of the scientific committee is preliminary and being finalised.

  • Miklós Sahin-Tóth
  • Tamás Gonda
  • Bálint Erőss
  • Andrea Szentesi
  • Zoltán Hajnády
  • Péter Hegyi
Planned invited speakers

Invited speakers listed in the draft programme. The list and speaker participation are preliminary; student presentations and other talks are included in the daily schedule.

  • Miklós Sahin-Tóth
  • Németh Balázs
  • Andrea Geisz-Fremy
  • Jason Bruce
  • Andraž Stožer
  • József Maléth
  • Rogier P. Voermans
  • John Gásdal Karstensen
  • Dhiraj Yadav
  • Soumya Jagannath Mahapatra
  • Hana Algül
  • Christopher Lee Wolfgang
  • Tamás Gonda
  • Matteo Tacelli
  • Vinciane Rebours
  • Sanjay Pandanaboyana
  • Cecilia Binda
  • Nitin Jagtap
  • Viktória Venglovecz

Contact

Enquiries about registration, participation and the programme.

hpsg2026@gmail.com

HPSG 2026 · Preliminary information · Subject to change.